Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Anticholinergics in the pipeline at Sumitomo for urinary incontinence

June 7, 2000

Abbott discloses potential new treatments for urinary incontinence and sexual dysfunction

June 6, 2000

Inhibitors of Na+/H+ exchange remain a focus of research at Aventis

June 5, 2000

Vivus seeks E.U. marketing approval for Alibra

June 1, 2000

Australian researchers discover novel conotoxin peptides that inhibit neuronal amine transporters

May 31, 2000

CVT-124 assessed in cirrhotic patients with ascites

May 29, 2000

Senetek acquires rights to novel compounds for topical treatment of sexual dysfunction

May 26, 2000

VPA-985 useful in hyponatremia

May 25, 2000

Therapeutic and marketing potential expand for Cystistat

May 25, 2000

Two new series of PDE5 inhibitors claimed by Pfizer

May 19, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...